Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MERCK PROSCAR ADS HAVE CONTRIBUTED TO INCREASED BPH DIAGNOSES

Executive Summary

MERCK PROSCAR ADS HAVE CONTRIBUTED TO INCREASED BPH DIAGNOSES by physicians, Merck U.S. Human Health Business Manager Keith Yothers maintained at a June 6 session on direct-to-consumer advertising at the Drug Information Association annual meeting in Washington, D.C. Yothers suggested that one reason for the jump in diagnoses of benign prostatic hyperplasia has been an effort to educate both consumers and physicians "since an 8 X 11 DTC ad can't communicate all the information about the product that a consumer might use."

Latest Headlines
See All
UsernamePublicRestriction

Register

PS024613

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel